In a meta-analysis of nine randomized controlled trials, adults had an average lean mass loss of 2.5 kg with GLP-1 therapy. More research is needed to examine the implications of lean mass loss ...
A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with ...